In addition, GRK5/ACTC1 co-expression was associated with the following factors: histology, FIGO stage, lymph node metastasis, intraperitoneal metastasis, intestinal metastasis, vital status, differentiation grade, and ascites with tumor cells. This evidence concerns the gene GRK5 and neoplasm.